substance p has been researched along with Bullous Dermatoses in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, SM; Khanani, AM; Reid, TW; Stetson, CL | 1 |
Khalil, Z; Modig, M; Nyberg, F; Sanderson, K | 1 |
Ekman, R; Möller, H; Wallengren, J | 1 |
3 other study(ies) available for substance p and Bullous Dermatoses
Article | Year |
---|---|
Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance p and insulinlike growth factor I for neurotrophic keratitis.
Topics: Accidents, Traffic; Administration, Topical; Child, Preschool; Cornea; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Insulin-Like Growth Factor I; Keratitis; Ophthalmic Solutions; Skin Diseases, Vesiculobullous; Substance P; Trigeminal Nerve Diseases | 2004 |
Modulation of peripheral inflammation by locally administered endomorphin-1.
Topics: Administration, Topical; Analgesics, Opioid; Animals; Blister; Blood Flow Velocity; Electric Stimulation; Male; Naloxone; Neurogenic Inflammation; Oligopeptides; Plasma; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Sciatic Nerve; Skin Diseases, Vesiculobullous; Substance P; Vasodilation | 1999 |
Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease.
Topics: Adolescent; Adult; Aged; Blister; Chromatography, High Pressure Liquid; Dermatitis; Female; Humans; Male; Middle Aged; Radioimmunoassay; Skin Diseases, Vesiculobullous; Substance P; Vasoactive Intestinal Peptide | 1986 |